Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Behnisch

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 24, 2004
[3D-visualization by MRI for surgical planning of Wilms tumors]J P Schenk, K-L Waag, N Graf, et al.
Klinische Padiatrie|June 2, 2010
Novel homozygous mutation (c.175delG) in platelet glycoprotein ITGA2B gene as cause of Glanzmann's thrombasthenia type IC Vannier, W Behnisch, I Bartsch, et al.
Leukemia|February 16, 2000
3 x 14 mg/m2 idarubicin during induction: results of a pilot study in children with AMLU Creutzig, D Körholz, C M Niemeyer, et al.
Klinische Padiatrie|September 20, 2000
Toxicity and effectiveness of high-dose idarubicin during AML induction therapy: results of a pilot study in childrenU Creutzig, D Körholz, C M Niemeyer, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 24, 2004
[3D-visualization by MRI for surgical planning of Wilms tumors]J P Schenk, K-L Waag, N Graf, et al.
Klinische Padiatrie|June 2, 2010
Novel homozygous mutation (c.175delG) in platelet glycoprotein ITGA2B gene as cause of Glanzmann's thrombasthenia type IC Vannier, W Behnisch, I Bartsch, et al.
Leukemia|February 16, 2000
3 x 14 mg/m2 idarubicin during induction: results of a pilot study in children with AMLU Creutzig, D Körholz, C M Niemeyer, et al.
Klinische Padiatrie|September 20, 2000
Toxicity and effectiveness of high-dose idarubicin during AML induction therapy: results of a pilot study in childrenU Creutzig, D Körholz, C M Niemeyer, et al.
Pageof 2